Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N014554 |
| CAS No | NA |
| Mol.F. | C49H53F2N9O7 |
| Mol.Wt. | 918.0 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141331 |
| CAS No | NA |
| Mol.F. | C37H67N3O14 |
| Mol.Wt. | 778.0 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141332 |
| CAS No | NA |
| Mol.F. | C37H69N3O13 |
| Mol.Wt. | 764 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0141333 |
| CAS No | NA |
| Mol.F. | C11H12ClN3O4 |
| Mol.Wt. | 285.7 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0141334 |
| CAS No | NA |
| Mol.F. | C27H28ClN5O6 |
| Mol.Wt. | 554.0 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141335 |
| CAS No | NA |
| Mol.F. | C11H12ClN3O4 |
| Mol.Wt. | 285.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141336 |
| CAS No | NA |
| Mol.F. | C20H25ClN4O4 |
| Mol.Wt. | 420.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141337 |
| CAS No | NA |
| Mol.F. | C25H26N6O6 |
| Mol.Wt. | 506.5 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0141338 |
| CAS No | NA |
| Mol.F. | C25H27N7O5 |
| Mol.Wt. | 505.5 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141339 |
| CAS No | NA |
| Mol.F. | C20H26N4O5 |
| Mol.Wt. | 402.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141340 |
| CAS No | NA |
| Mol.F. | C25H25N5O7 |
| Mol.Wt. | 507.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141341 |
| CAS No | NA |
| Mol.F. | C24H27N5O6 |
| Mol.Wt. | 481.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141342 |
| CAS No | NA |
| Mol.F. | C7H7N3O2 |
| Mol.Wt. | 165.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141343 |
| CAS No | NA |
| Mol.F. | C14H20N4O2 |
| Mol.Wt. | 276.3 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141344 |
| CAS No | NA |
| Mol.F. | C16H17BrN2O2 |
| Mol.Wt. | 349.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141345 |
| CAS No | NA |
| Mol.F. | C17H15ClN4O2 |
| Mol.Wt. | 342.8 |
| INV STATUS | UNDER SYNTHESIS |